Literature DB >> 17561121

The effects of subthalamic nucleus deep brain stimulation on parkinsonian tremor.

Alan Diamond1, Joohi Shahed, Joseph Jankovic.   

Abstract

Deep brain stimulation (DBS) of the ventral intermediate (Vim) nucleus of the thalamus has been the target of choice for patients with disabling essential tremor or medication refractory parkinsonian tremor. Recently there is evidence that the subthalamic nucleus (STN) should be the targets for patients with tremor associated with Parkinson's disease (PD). To assess the effects of STN DBS on parkinsonian tremor, eight consecutive patients with PD and disabling tremor were videotaped using a standardized tremor protocol. Evaluations were performed at least 12 h after last dose of medication with the DBS turned off followed by optimal DBS on state. A rater blinded to DBS status evaluated randomized video segments with the tremor components of the Unified Parkinson Disease Rating Scale (UPDRS) and Tremor Rating Scale (TRS). Compared with DBS off state there were significant improvements in mean UPDRS tremor score 79.4% (p=0.008), total TRS score 69.9% (p=0.008) and upper extremity 92.5% (p=0.008) TRS subscore. Functional improvement was noted with pouring liquids. Our findings provide support that STN DBS is an effective treatment of tremor associated with PD.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17561121     DOI: 10.1016/j.jns.2007.05.002

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  10 in total

Review 1.  Mechanisms and targets of deep brain stimulation in movement disorders.

Authors:  Matthew D Johnson; Svjetlana Miocinovic; Cameron C McIntyre; Jerrold L Vitek
Journal:  Neurotherapeutics       Date:  2008-04       Impact factor: 7.620

2.  Subthalamic nucleus modulation of the pontine nuclei and its targeting of the cerebellar cortex.

Authors:  Ramakrishnan K B; Joanna Krzyspiak; Kamran Khodakhah
Journal:  J Neurosci       Date:  2022-05-31       Impact factor: 6.709

Review 3.  Current Practice and the Future of Deep Brain Stimulation Therapy in Parkinson's Disease.

Authors:  Leonardo Almeida; Wissam Deeb; Chauncey Spears; Enrico Opri; Rene Molina; Daniel Martinez-Ramirez; Aysegul Gunduz; Christopher W Hess; Michael S Okun
Journal:  Semin Neurol       Date:  2017-05-16       Impact factor: 3.420

4.  Deep brain stimulation for the treatment of Parkinson's disease: efficacy and safety.

Authors:  Nader Pouratian; Sandeep Thakkar; Won Kim; Jeff M Bronstein
Journal:  Degener Neurol Neuromuscul Dis       Date:  2012-09-04

5.  Novel applications of deep brain stimulation.

Authors:  Tejas Sankar; Travis S Tierney; Clement Hamani
Journal:  Surg Neurol Int       Date:  2012-01-14

6.  Subregional 6-[18F]fluoro-ʟ-m-tyrosine uptake in the striatum in Parkinson's disease.

Authors:  Sayaka Asari; Ken-ichi Fujimoto; Akihiro Miyauchi; Toshihiko Sato; Imaharu Nakano; Shin-ichi Muramatsu
Journal:  BMC Neurol       Date:  2011-03-23       Impact factor: 2.474

7.  Current approaches to the treatment of Parkinson's disease.

Authors:  Joseph Jankovic; L Giselle Aguilar
Journal:  Neuropsychiatr Dis Treat       Date:  2008-08       Impact factor: 2.570

8.  Comparison of VIM and STN DBS for Parkinsonian Resting and Postural/Action Tremor.

Authors:  Raminder Parihar; Ron Alterman; Efstathios Papavassiliou; Daniel Tarsy; Ludy C Shih
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2015-07-06

9.  Resolution of tardive tremor after bilateral subthalamic nucleus deep brain stimulation placement.

Authors:  Samir Kashyap; Rita Ceponiene; Paras Savla; Jacob Bernstein; Hammad Ghanchi; Ajay Ananda
Journal:  Surg Neurol Int       Date:  2020-12-16

10.  Exploring the effects of deep brain stimulation and vision on tremor in Parkinson's disease - benefits from objective methods.

Authors:  Per-Anders Fransson; Maria H Nilsson; Diederick C Niehorster; Marcus Nyström; Stig Rehncrona; Fredrik Tjernström; Måns Magnusson; Rolf Johansson; Mitesh Patel
Journal:  J Neuroeng Rehabil       Date:  2020-04-25       Impact factor: 4.262

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.